Universitätsklinikum Schleswig-Holstein (UKSH)

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Sauer T, Crysandt M, et al. Journal article Influence of Turkish origin on hematology reference intervals in the German population (2021) Mayr FX, Bertram A, Cario H, Frühwald MC, Groß HJ, Groening A, Grützner S, et al. Journal article DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status (2021) Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Mueller V, et al. Journal article Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (BMC Cancer, (2021), 21, 1, (920), 10.1186/s12885-021-08656-0) (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article, Erratum The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis (2021) Iking-Konert C, Wallmeier P, Arnold S, Adler S, De Groot K, Hellmich B, Hoyer BF, et al. Journal article An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod (2021) Hesselstrand R, Distler J, Riemekasten G, Wuttge DM, Torngren M, Nyhlen HC, Andersson F, et al. Journal article Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans (2021) Schwarm C, Gola D, Holtsche MM, Dieterich A, Bhandari A, Freitag M, Nürnberg P, et al. Journal article Indications for the surgical management of pancreatic neoplasms (2021) Brunner M, Belyaev O, Boesch F, Keck T, Witzigmann H, Grützmann R, Uhl W, Werner J Journal article, Review article Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4 (2021) Kayser S, Martinez-Cuadron D, Hanoun M, Stoelzel F, Gil C, Reinhardt HC, Aguiar E, et al. Conference contribution Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Conference contribution